Zynex Inc. (ZYXI)

[UFO]

Zynex to Present at the SeeThruEquity Disruptive Growth Company Showcase
PR Newswire
LONE TREE, Colo., Sept. 21, 2017
LONE TREE, Colo., Sept. 21, 2017 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that Thomas Sandgaard, Founder and CEO, will present at the SeeThruEquity Disruptive Growth Company Showcase on Wednesday September 27, 2017 at 11:30 am EDT. The conference will be held at the Grand Hyatt in New York City.  Management will also be meeting with members of the investment community during one-on-one meetings.
A live audio webcast and copy of the presentation can be accessed through the "Investors" section of the Company's website at www.zynex.com.  Interested parties unable to listen to the live webcast can access an archived version on the Company's website for approximately 90 days.  
About Zynex
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex is also developing a new blood volume monitor for use in hospitals and surgery centers. For additional information, please visit: Zynex.com.